Filing Details
- Accession Number:
- 0001209191-12-057415
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-13 16:30:36
- Reporting Period:
- 2012-12-11
- Filing Date:
- 2012-12-13
- Accepted Time:
- 2012-12-13 16:30:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816284 | Celgene Corp | CELG | Pharmaceutical Preparations (2834) | 222711928 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1247024 | Gilla Kaplan | C/O Celgene Corporation 86 Morris Avenue Summit NJ 07901 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-12-11 | 48,000 | $8.41 | 54,055 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-12-11 | 32,400 | $81.42 | 21,655 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2012-12-11 | 48,000 | $0.00 | 48,000 | $8.41 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-06-10 | No | 4 | M | Direct |
Footnotes
- This sale was executed pursuant to a prearranged trading plan compliant with Rule 10b5-1.
- The option was fully exercisable.
- The option was issued pursuant to the Company's 1995 Non-Employee Director's Incentive Plan.
Billionaire Hedge Funds
